| Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry M Gianfrancesco, KL Hyrich, S Al-Adely, L Carmona, MI Danila, L Gossec, ... Annals of the rheumatic diseases 79 (7), 859-866, 2020 | 1182 | 2020 |
| Low-dose methotrexate for the prevention of atherosclerotic events PM Ridker, BM Everett, A Pradhan, JG MacFadyen, DH Solomon, ... New England Journal of Medicine 380 (8), 752-762, 2019 | 1164 | 2019 |
| Persistence and evolution of SARS-CoV-2 in an immunocompromised host B Choi, MC Choudhary, J Regan, JA Sparks, RF Padera, X Qiu, ... New England Journal of Medicine 383 (23), 2291-2293, 2020 | 1161 | 2020 |
| 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis L Fraenkel, JM Bathon, BR England, EW St. Clair, T Arayssi, K Carandang, ... Arthritis & Rheumatology 73 (7), 1108-1123, 2021 | 1078 | 2021 |
| Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry A Strangfeld, M Schäfer, MA Gianfrancesco, S Lawson-Tovey, JW Liew, ... Annals of the rheumatic diseases 80 (7), 930-942, 2021 | 694* | 2021 |
| Development of a definition of postacute sequelae of SARS-CoV-2 infection T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ... Jama 329 (22), 1934-1946, 2023 | 324 | 2023 |
| Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’ KM D’Silva, N Serling-Boyd, R Wallwork, T Hsu, X Fu, EM Gravallese, ... Annals of the rheumatic diseases 79 (9), 1156-1162, 2020 | 311 | 2020 |
| A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19 AHJ Kim, JA Sparks, JW Liew, MS Putman, F Berenbaum, ... Annals of Internal Medicine 172 (12), 819-821, 2020 | 277* | 2020 |
| Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study B Lu, LT Hiraki, JA Sparks, S Malspeis, CY Chen, JA Awosogba, ... Annals of the rheumatic diseases 73 (11), 1914-1922, 2014 | 269 | 2014 |
| Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance … JA Sparks, ZS Wallace, AM Seet, MA Gianfrancesco, Z Izadi, KL Hyrich, ... Annals of the rheumatic diseases 80 (9), 1137-1146, 2021 | 222 | 2021 |
| Rheumatoid arthritis and mortality among women during 36 years of prospective follow‐up: results from the Nurses’ Health Study JA Sparks, SC Chang, KP Liao, B Lu, AR Fine, DH Solomon, ... Arthritis care & research 68 (6), 753-762, 2016 | 206 | 2016 |
| Long-term dietary quality and risk of developing rheumatoid arthritis in women Y Hu, JA Sparks, S Malspeis, KH Costenbader, FB Hu, EW Karlson, B Lu Annals of the rheumatic diseases 76 (8), 1357-1364, 2017 | 179 | 2017 |
| Adverse effects of low-dose methotrexate: a randomized trial DH Solomon, RJ Glynn, EW Karlson, F Lu, C Corrigan, J Colls, C Xu, ... Annals of internal medicine 172 (6), 369-380, 2020 | 175 | 2020 |
| Rheumatoid arthritis disease activity predicting incident clinically‐apparent RA‐associated interstitial lung disease: A prospective cohort study JA Sparks, X He, J Huang, EA Fletcher, A Zaccardelli, HM Friedlander, ... Arthritis & Rheumatology 71 (9), 1472-1482, 2019 | 170* | 2019 |
| Sugar-sweetened soda consumption and risk of developing rheumatoid arthritis in women Y Hu, KH Costenbader, X Gao, M Al-Daabil, JA Sparks, DH Solomon, ... The American journal of clinical nutrition 100 (3), 959-967, 2014 | 170 | 2014 |
| Communicating genetic risk information for common disorders in the era of genomic medicine DM Lautenbach, KD Christensen, JA Sparks, RC Green Annual review of genomics and human genetics 14 (1), 491-513, 2013 | 162 | 2013 |
| Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey SE Sattui, JW Liew, K Kennedy, E Sirotich, M Putman, TT Moni, A Akpabio, ... RMD open 7 (3), e001814, 2021 | 154 | 2021 |
| SARS–CoV‐2 infection and COVID‐19 outcomes in rheumatic diseases: a systematic literature review and meta‐analysis R Conway, AA Grimshaw, MF Konig, M Putman, A Duarte‐García, ... Arthritis & Rheumatology 74 (5), 766-775, 2022 | 133 | 2022 |
| Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19 Z Izadi, EJ Brenner, SK Mahil, N Dand, ZZN Yiu, M Yates, RC Ungaro, ... JAMA network open 4 (10), e2129639-e2129639, 2021 | 117 | 2021 |
| Cigarette smoking and the risk of systemic lupus erythematosus, overall and by anti-double stranded DNA antibody subtype, in the Nurses’ Health Study cohorts M Barbhaiya, SK Tedeschi, B Lu, S Malspeis, D Kreps, JA Sparks, ... Annals of the rheumatic diseases 77 (2), 196-202, 2018 | 116 | 2018 |
Zachary S. WallacePhysician-Scientist, Rheumatology Unit, Massachusetts General Hospital在 mgh.harvard.edu 的电子邮件经过验证
